Furthermore, JLD activates AMPK to protect β-cells and stimulates the PPARα/ABCA1 pathway, thereby improving glucose–lipid metabolism, reducing hepatic lipid deposition, and alleviating insulin resistance (51). The gene discussed is ABCA1; the disease is Insulin resistance.